Impact of ID pharmacist review of OPAT services – Full Text

"We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care" Ross et al (2026).

"We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care" Ross et al (2026).

ReTweet

Abstract:

We previously characterized a reduction in unscheduled care following implementation of ID pharmacist review of outpatient parenteral antimicrobial therapy plans for patients discharging from acute care. In this report we demonstrate the cost avoidance that this intervention would be expected to generate for patients enrolled in value-based-care plans.

Reference:

Ross JK, Boeser KD, Hordyk M, Manhani BS, Hirsch EB, Evans MD, Sieling WD, Kline SE, Galdys AL. Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospital. Antimicrob Steward Healthc Epidemiol. 2026 Apr 1;6(1):e86. doi: 10.1017/ash.2026.10329. PMID: 42038639; PMCID: PMC13104560.